Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · IEX Real-Time Price · USD
2.030
-0.060 (-2.87%)
At close: Jul 2, 2024, 4:00 PM
1.980
-0.050 (-2.46%)
After-hours: Jul 2, 2024, 4:28 PM EDT
Protara Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for TARA stock have an average target of 25, with a low estimate of 22 and a high estimate of 30. The average target predicts an increase of 1,131.53% from the current stock price of 2.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 6, 2024.
Analyst Ratings
The average analyst rating for TARA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,033.00% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +1,377.83% | Apr 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +1,033.00% | Apr 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,033.00% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,033.00% | Aug 4, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.93
from -3.57
EPS Next Year
-4.23
from -3.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 16.2M | 278.3M | 446.3M |
| Avg | n/a | n/a | 13.5M | 102.7M | 200.6M |
| Low | n/a | n/a | 10.9M | 6.9M | 73.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,958.7% | 334.6% |
| Avg | - | - | - | 659.8% | 95.3% |
| Low | - | - | - | -49.2% | -28.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.10 | -1.90 | -2.68 | 3.41 | 8.45 |
| Avg | -3.93 | -4.23 | -3.73 | -0.82 | 1.89 |
| Low | -5.24 | -5.83 | -4.32 | -3.28 | -1.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.